rs2273684

This variant is located in the GSS gene.

GWAS Catalog Trait Associations (3)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

glomerular filtration rate

Allele T
OR 0.00
p 1.0e-44
N 765,348
Large GWAS
multi-ancestry
Allele T
OR 8.62
p 7.0e-18
N 350,514
Meta-analysisLarge GWAS
multi-ancestry
Allele T
OR 0.22
p 1.0e-11
N 312,296
Large GWAS
multi-ancestry

grip strength measurement

Allele T
OR 0.01
p 8.0e-24
N 404,112
Large GWAS
European

BMI-adjusted waist-hip ratio

Allele G
OR 0.02
p 6.0e-9
N 186,825
Major Consortium StudyLarge GWAS
European

ClinVar annotation

Benign☆☆☆
1 submitter
View on ClinVar →

Research that mentions this SNP (1)

Polymorphisms in oxidative stress‐related genes and postmenopausal breast cancer risk
AssociationN=2,409Petra Seibold et al.(2011)· International Journal of Cancer

Two-stage case-control study in Spanish population examining 76 polymorphisms in 27 oxidative stress-related genes for breast cancer susceptibility. Six SNPs (rs1052133 in OGG1, rs406113 and rs974334 in GPX6, rs2284659 in SOD3, rs4135225 in TXN, rs207454 in XDH) were significantly associated with breast cancer risk. A four-variant interaction (rs406113, rs974334, rs1052133, rs2284659) showed increased risk with OR = 1.75 [95% CI: 1.26-2.44], p-value = 0.0008.

Traits studied:Breast cancer

About GSS

Glutathione is important for a variety of biological functions, including protection of cells from oxidative damage by free radicals, detoxification of xenobiotics, and membrane transport. The protein encoded by this gene functions as a homodimer to catalyze the second step of glutathione biosynthesis, which is the ATP-dependent conversion of gamma-L-glutamyl-L-cysteine to glutathione. Defects in this gene are a cause of glutathione synthetase deficiency. [provided by RefSeq, Jul 2008]

View all GSS variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…